Karyopharm Therapeutics Inc. 4
4 · Karyopharm Therapeutics Inc. · Filed Jun 17, 2016
Insider Transaction Report
Form 4
WEG KENNETH E
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2016-06-16+10,000→ 10,000 totalExercise: $8.06Exp: 2026-06-15→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option vests as to 100% of the underlying shares on June 16, 2017, provided that the holder continues to serve as a director of the issuer through such date.